The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China

<div>Distribution of childhood TB patients enrolled in this study. The number annotated in the figure represents the number of childhood TB patients from each province. The background map was created using Matlab 7.0 software (The MathWorks, MA, USA, <a href="https://www.mathworks.com/products/matlab">https://www.mathworks.com/products/matlab</a>), Adobe Photoshop 6.0 (Adobe Systems Inc., CA, USA, <a href="http://www.adobe.com/cn/products/photoshop.html">http://www.adobe.com/cn/products/photoshop.html</a>), and Adobe Illustrator CS4 (Adobe Systems Inc., CA, USA, <a href="http://www.adobe.com/products/illustrator.html">http://www.adobe.com/products/illustrator.html</a>).</div>

BioMed Research International

fig2

Figure 2

Figure 2: The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China 

Figure 2 | The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China 